Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial
August 20, 2014 at 08:03 AM EDT
Shares surge 40% in premarket trade on positive news from Phase 3 study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.